Home The single-use bioreactor track enters a diversified competition stage of "technology adaptation + scenario segmentation"

The single-use bioreactor track enters a diversified competition stage of "technology adaptation + scenario segmentation"

CST Updated Nov 14, 2025 14:39

While global giants like Sartorius, Thermo Fisher, and Cytiva lead in performance, Chinese innovators are winning through strategic differentiation:

  • Tofflon: 30% lower consumable costs & 2-month delivery

  • CNBG ToCell: 40% lower energy use & >50% supply chain localization

  • Baigaole: 50-70% cost reduction with innovative magnetic agitation


Dive into the new competitive landscape in our latest VBtalk:



Watch the previous video: SUBs: dominating over 70% of the global market, giants monopolize the discourse power of core